Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Newly Formulated Tylenol vs Tylenol 8H ER in Healthy Subjects
NCT04214691Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetaminophen in pain and fever (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Maximum Observed Analyte Concentration and Area Under the Concentration-time Curve From Time 0 to Time of the Last Measurable Concentration. Started Dec 2019; status: completed.
02
Drugs
acetaminophen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT04214691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214691.